Selena Lorrey - School of Medicine, Duke University

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 37 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

IMMU-05. TNFR2 IS A NOVEL MARKER OF EXHAUSTION AND TNFR2 BLOCKADE IMPROVES SUBCUTANEOUS TUMOR CONTROL

Alexandra Hoyt-Miggelbrink, Jessica Waibl Polania,Aditya Mohan, Lucas Wachsmuth,Selena Lorrey, Emily Lerner,Daniel Wilkinson,Andrew Hardigan, Emily Blandford,Kelly Hotchkiss, Saskia Hemmers, Sarah Cook Quackenbush, Katayoun Ayasoufi,Peter Fecci

Neuro-Oncologyno. Supplement_8 (2024)

引用0浏览0引用

Antigen Presentation by Tumor-Associated Macrophages Mediates Progenitor to Terminal Exhaustion Transition in GBM and Other Solid Tumors

Jessica Waibl Polania,Alexandra Hoyt-Miggelbrink,William H. Tomaszewski,Lucas P. Wachsmuth,Selena J. Lorrey,Daniel S. Wilkinson,Emily Lerner,Karolina Woroniecka,John B. Finlay,Peter E. Fecci

Neuro-Oncologyno. Supplement_8 (2024)

引用0浏览0引用

Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19 (vol 25, Pg 7046, 2019)

Maria Ormhoj,Irene Scarfo,Maria L. Cabral,Stefanie R. Bailey,Selena J. Lorrey,Amanda A. Bouffard,Ana P. Castano,Rebecca C. Larson,Lauren S. Riley,Andrea Schmidts, Bryan D. Choi, Rikke S. Andersen,Oriane Cedile,Charlotte G. Nyvold,Jacob H. Christensen,Morten F. Gjerstorff, Henrik J. Ditzel, David M. Weinstock, Torben Barington, Matthew J. Frigault, Marcela V. Maus

CLINICAL CANCER RESEARCH（2024）

引用0浏览0引用

TNFR2 loss leads to decreased TOX expression in T cells without affecting TIM3 and improves responses to tumor and chronic LCMV

Alexandra Hoyt-Miggelbrink,Jessica Waibl Polania,Luke Wachsmuth,Selena Lorrey,Aditya Mohan,Andrew Hardigan,Emily Blandford,Emily Lerner,Daniel Wilkinson,Kelly M. Hotchkiss,Sarah Cook,Saskia Hemmers,Anoop Patel,Katayoun Ayasoufi,Peter Fecci

biorxiv（2024）

引用0浏览0引用

Abstract PR-001: Beta-adrenergic Blockade Licenses the Use of Immunotherapy in Primary Brain Tumors and Brain Metastases

Selena Lorrey,Lucas P. Wachsmuth,Mackenzie Price,Corey Neff,Quinn T. Ostrom,Peter E. Fecci

Cancer researchno. 5_Supplement_1 (2024): PR-001

引用0浏览0引用

891 Beta-adrenergic Blockade Licenses the Use of Immunotherapy in Primary and Metastatic Brain Tumors

Selena Lorrey,Lucas Wachsmuth,Mackenzie Price,Corey Neff,Quinn Ostrom,Peter Fecci

CANCER RESEARCHno. 5 (2024)

引用0浏览0引用

CD8+ T Cells Maintain Killing of MHC-I-negative Tumor Cells Through the NKG2D–NKG2DL Axis

Emily C. Lerner,Karolina I. Woroniecka,Vincent M. D’Anniballe,Daniel S. Wilkinson,Aditya A. Mohan,Selena J. Lorrey,Jessica Waibl-Polania,Lucas P. Wachsmuth,Alexandra M. Miggelbrink,Joshua D. Jackson,Xiuyu Cui, Jude A. Raj,William H. Tomaszewski,Sarah L. Cook,John H. Sampson,Anoop P. Patel,Mustafa Khasraw,Michael D. Gunn,Peter E. Fecci

Nature cancerno. 9 (2023): 1258-1272

引用3浏览0WOSNATURE引用

A Novel MHC-Independent Mechanism of Tumor Cell Killing by CD8+ T Cells

Emily Lerner,Karolina Woroniecka,Vincent D’Anniballe,Daniel Wilkinson,Selena Lorrey,Jessica Waibl-Polania,Lucas Wachsmuth,Alexandra Miggelbrink, Jude Raj,Aditya Mohan,Sarah Cook,William Tomaszewski,Xiuyu Cui,Mustafa Khasraw,Michael D. Gunn,Peter E. Fecci

biorxiv（2023）

引用1浏览0引用

Systemic Immune Derangements Are Shared Across Various CNS Pathologies and Reflect Novel Mechanisms of Immune Privilege

Selena J Lorrey,Jessica Waibl Polania,Lucas P Wachsmuth,Alexandra Hoyt-Miggelbrink,Zachariah P Tritz,Ryan Edwards,Delaney M Wolf,Aaron J Johnson,Peter E Fecci,Katayoun Ayasoufi

Neuro-oncology advancesno. 1 (2023): vdad035-vdad035

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn